Review Timeline | CrossMark Policy | ClinMed Features
logo
International Journal of

Cancer and Clinical ResearchISSN: 2378-3419

Archive

 Open Access DOI:10.23937/2378-3419/1410170

Oncology and Reproductive Outcomes Over Sixteen Years of Malignant Ovarian Germ Cell Tumors Treated with Fertility Sparing Surgery

Muangloei Rungoutok, MD and Prapaporn Suprasert, MD

Article Type: Original Article | First Published: June 30, 2022

Malignant Ovarian Germ Cell Tumors (MOGCT) are rare and frequently occur in the young reproductive age and the oncologic and reproductive outcome after Fertility-Sparing Surgery (FSS) this disease is still limited....

 Open Access DOI:10.23937/2378-3419/1410169

Carcinosarcoma EX Pleomorphic Adenoma of Parotid: An Unusual Entity, A Report of Two Cases with Brief Review of Literature

Aparna Devi, MD, DM, Usha Amirtha, MD, Geeta V Patil Okaly, MD and Raghavendra HV, MD

Article Type: Case Report | First Published: June 30, 2022

A 58-year-old male, underwent total parotidectomy for longstanding preauricular swelling. Histomorphology revealed a biphasic neoplasm composed of carcinoma with plasmacytoid morphology and osteosarcoma in the background of pleomorphic adenoma. Carcinoma component was confirmed to be myoepithelial carcinoma by immunohistochemistry. The patient presented with local recurrence two months later....

 Open Access DOI:10.23937/2378-3419/1410166

Chemoprevention of 1,2 Dimethyl Hydrazine-Induced Colon Tumor in Albino Rat by Meloxicam and its Correlation with Immunoassay of Serum CEA

Saeed Mahmoud Saeed Mohamed, Afaf Mosaad Amin, Suzanne William Skander, Taha Ismail Mahmoud Hewala, Eithar Omer Mohamed Saleh, Aisha Mohammed Osman Salih, Sabah Ali Mugahed Al-Qadasi, Marwan Mustafa Badawi and Mahmoud Assem Hamed

Article Type: Research Article | First Published: April 28, 2022

Colorectal Cancer (CRC) is among the most common types of cancer in the world. Globally a steadily increasing proportion of elderly people in the world result in approximately 16 million new cases of cancer by the year 2021. Regarding treatment; Meloxicam was shown to prevent the initiation of chemical-induced tumors, and considered as anticancer agent by virtue of its anti-proliferative effect, capacity for cell cycle arrest, and pro-apoptotic effects, also acted as free radical scavenger, in p...

 Open Access DOI:10.23937/2378-3419/1410168

Squamous Cell Carcinoma Arising from Inverted Papilloma

Carlos Santiago Ruggeri, Claudina Aguirre, Claudia Esper and Guillermo Sebastian Aragon

Article Type: Research Article | First Published: May 28, 2022

To determine the incidence of squamous cell carcinoma in patients with IP of the paranasal sinuses andlocal control in patients treated for cancer associated with IP....

 Open Access DOI:10.23937/2378-3419/1410167

Proposed Immunology of the Spontaneous Remission of Acute Myleiod Leukemia Treated with G-CSF

Behzad Niakan

Article Type: Hypotheses | First Published: April 29, 2022

It is suggested that the spontaneous remission of acute myeloid leukemia, particularly hypoplastic acute myeloid leukemia seen after G-CSF treatment is possibly due to G-CSF augmenting an acute inflammatory response. The acute inflammatory response is one occurring during a low count of activated platelets. Furthermore, it appears if a low platelet count (absence of hyper-coagulation or thrombocytosis) is present then G-CSF administration are more likely to induce a remission of acute myeloid le...

 Open Access DOI:10.23937/2378-3419/1410165

Treatment of Cancer Patients in the Era of the Covid-19 Pandemic

Budi Tulaka, Harlinda Haroen, Linda Wilhelma Ancella Rotty, Pearla Fidei Cindy Lasut and Cecilia Hendratta

Article Type: Research Article | First Published: April 18, 2022

Coronavirus Disease 2019 (COVID-19) is an outbreak of respiratory disease caused by novel coronavirus and has reached pandemic state. Cancer patients have increase susceptibility to infection caused by the malignancy itself and anticancer systemic therapy. Based on individual patient assessment, the oncologist's decision regarding the need for immediate oncological intervention classifies patients into 'urgent' and 'non-urgent' conditions. Consideration of risk and benefit for active interventio...

Volume 9
Issue 1